Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease

Identifieur interne : 003171 ( Main/Exploration ); précédent : 003170; suivant : 003172

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease

Auteurs : Katherine J. Schweitzer [Allemagne] ; Rüdiger Hilker [Allemagne] ; Uwe Walter [Allemagne] ; Lothar Burghaus [Allemagne] ; Daniela Berg [Allemagne]

Source :

RBID : ISTEX:738D9B8A40CDE715620F856108F49C34D55105C4

Descripteurs français

English descriptors

Abstract

Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound marker may give any implications for the rate of PD progression, we sonographically investigated 16 PD patients in whom the rate of progression had been determined by serial 18‐fluorodopa positron emission tomography over a follow‐up period of 65.7 ± 26.7 months. We found a significant negative correlation between the right‐to‐left averaged SN echogenic size and the rate of disease progression in the caudate nucleus and in the putamen. There was a tendency towards a younger age at symptom onset in patients with SN hyperechogenicity. It may therefore be hypothesized that a differing influence of factors determining SN echogenicity early in life and impairing forces occurring later in life may account for different pathogenetic subgroups of idiopathic PD. © 2005 Movement Disorder Society

Url:
DOI: 10.1002/mds.20669


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease</title>
<author>
<name sortKey="Schweitzer, Katherine J" sort="Schweitzer, Katherine J" uniqKey="Schweitzer K" first="Katherine J." last="Schweitzer">Katherine J. Schweitzer</name>
</author>
<author>
<name sortKey="Hilker, Rudiger" sort="Hilker, Rudiger" uniqKey="Hilker R" first="Rüdiger" last="Hilker">Rüdiger Hilker</name>
</author>
<author>
<name sortKey="Walter, Uwe" sort="Walter, Uwe" uniqKey="Walter U" first="Uwe" last="Walter">Uwe Walter</name>
</author>
<author>
<name sortKey="Burghaus, Lothar" sort="Burghaus, Lothar" uniqKey="Burghaus L" first="Lothar" last="Burghaus">Lothar Burghaus</name>
</author>
<author>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:738D9B8A40CDE715620F856108F49C34D55105C4</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20669</idno>
<idno type="url">https://api.istex.fr/document/738D9B8A40CDE715620F856108F49C34D55105C4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002953</idno>
<idno type="wicri:Area/Istex/Curation">002953</idno>
<idno type="wicri:Area/Istex/Checkpoint">001C30</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Schweitzer K:substantia:nigra:hyperechogenicity</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16114024</idno>
<idno type="wicri:Area/PubMed/Corpus">002F02</idno>
<idno type="wicri:Area/PubMed/Curation">002F02</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A77</idno>
<idno type="wicri:Area/Ncbi/Merge">001410</idno>
<idno type="wicri:Area/Ncbi/Curation">001410</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001410</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Schweitzer K:substantia:nigra:hyperechogenicity</idno>
<idno type="wicri:Area/Main/Merge">004484</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0135503</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C79</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001042</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001886</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Schweitzer K:substantia:nigra:hyperechogenicity</idno>
<idno type="wicri:Area/Main/Merge">004981</idno>
<idno type="wicri:Area/Main/Curation">003171</idno>
<idno type="wicri:Area/Main/Exploration">003171</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease</title>
<author>
<name sortKey="Schweitzer, Katherine J" sort="Schweitzer, Katherine J" uniqKey="Schweitzer K" first="Katherine J." last="Schweitzer">Katherine J. Schweitzer</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hilker, Rudiger" sort="Hilker, Rudiger" uniqKey="Hilker R" first="Rüdiger" last="Hilker">Rüdiger Hilker</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University Hospital, Cologne</wicri:regionArea>
<wicri:noRegion>Cologne</wicri:noRegion>
<wicri:noRegion>Cologne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Walter, Uwe" sort="Walter, Uwe" uniqKey="Walter U" first="Uwe" last="Walter">Uwe Walter</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Rostock, Rostock</wicri:regionArea>
<wicri:noRegion>Rostock</wicri:noRegion>
<wicri:noRegion>Rostock</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Burghaus, Lothar" sort="Burghaus, Lothar" uniqKey="Burghaus L" first="Lothar" last="Burghaus">Lothar Burghaus</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University Hospital, Cologne</wicri:regionArea>
<wicri:noRegion>Cologne</wicri:noRegion>
<wicri:noRegion>Cologne</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Genetics, University of Tübingen, Tübingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-01">2006-01</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="94">94</biblScope>
<biblScope unit="page" to="98">98</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">738D9B8A40CDE715620F856108F49C34D55105C4</idno>
<idno type="DOI">10.1002/mds.20669</idno>
<idno type="ArticleID">MDS20669</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Echoencephalography</term>
<term>Female</term>
<term>Humans</term>
<term>Locus niger</term>
<term>Male</term>
<term>Mathematical Computing</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (ultrasonography)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Positron-Emission Tomography</term>
<term>Prognosis</term>
<term>SN hyperechogenicity</term>
<term>Sensitivity and Specificity</term>
<term>Sonography</term>
<term>Substantia Nigra (ultrasonography)</term>
<term>disease progression</term>
<term>predisposition</term>
<term>transcranial sonography (TCS)</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrasonography" xml:lang="en">
<term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Echoencephalography</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mathematical Computing</term>
<term>Middle Aged</term>
<term>Positron-Emission Tomography</term>
<term>Prognosis</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Exploration ultrason</term>
<term>Locus niger</term>
<term>Parkinson maladie</term>
<term>Système nerveux pathologie</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound marker may give any implications for the rate of PD progression, we sonographically investigated 16 PD patients in whom the rate of progression had been determined by serial 18‐fluorodopa positron emission tomography over a follow‐up period of 65.7 ± 26.7 months. We found a significant negative correlation between the right‐to‐left averaged SN echogenic size and the rate of disease progression in the caudate nucleus and in the putamen. There was a tendency towards a younger age at symptom onset in patients with SN hyperechogenicity. It may therefore be hypothesized that a differing influence of factors determining SN echogenicity early in life and impairing forces occurring later in life may account for different pathogenetic subgroups of idiopathic PD. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Tübingen</li>
</region>
<settlement>
<li>Tübingen</li>
</settlement>
</list>
<tree>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Schweitzer, Katherine J" sort="Schweitzer, Katherine J" uniqKey="Schweitzer K" first="Katherine J." last="Schweitzer">Katherine J. Schweitzer</name>
</region>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
<name sortKey="Burghaus, Lothar" sort="Burghaus, Lothar" uniqKey="Burghaus L" first="Lothar" last="Burghaus">Lothar Burghaus</name>
<name sortKey="Hilker, Rudiger" sort="Hilker, Rudiger" uniqKey="Hilker R" first="Rüdiger" last="Hilker">Rüdiger Hilker</name>
<name sortKey="Walter, Uwe" sort="Walter, Uwe" uniqKey="Walter U" first="Uwe" last="Walter">Uwe Walter</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003171 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003171 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:738D9B8A40CDE715620F856108F49C34D55105C4
   |texte=   Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024